TCW Group’s Genomic Health, Inc. GHDX Stock Holding History

TCW Group’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-11,918	Closed	-$768K	–	350
2018 Q4	$768K	Buy	+11,918	New	+$835K	0.01%	273
2016 Q1	–	Sell	-10,565	Closed	-$372K	–	710
2015 Q4	$372K	Buy	+10,565	New	+$283K	﹤0.01%	655
2015 Q3	–	Sell	-12,445	Closed	-$345K	–	721
2015 Q2	$345K	Hold	12,445	–	–	﹤0.01%	647
2015 Q1	$381K	Sell	12,445 -900	-7%	-$28.6K	﹤0.01%	738
2014 Q4	$426K	Buy	13,345 +1,450	+12%	+$47.2K	﹤0.01%	711
2014 Q3	$337K	Hold	11,895	–	–	﹤0.01%	717
2014 Q2	$326K	Hold	11,895	–	–	﹤0.01%	721
2014 Q1	$314K	Sell	11,895 -11,550	-49%	-$331K	﹤0.01%	738
2013 Q4	$686K	Hold	23,445	–	–	﹤0.01%	717
2013 Q3	$717K	Hold	23,445	–	–	﹤0.01%	712
2013 Q2	$743K	Buy	+23,445	New	+$770K	﹤0.01%	688

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCW Group's GHDX Position: Q1 2019 in Review

TCW Group sold out of Genomic Health, Inc. (GHDX) in Q1 2019, closing a stake of 11,918 shares — an estimated $768K sold.

TCW Group first reported a position in GHDX in Q2 2013 and held it in 11 quarters. The position peaked at $768K in Q4 2018. 267 funds tracked by Wall St. Rank hold GHDX as of Q1 2019.

TCW Group reported no remaining Genomic Health, Inc. position as of Q1 2019 after selling out during the quarter.
TCW Group sold 11,918 Genomic Health, Inc. shares in Q1 2019, an estimated $768K.
TCW Group first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 11 quarters.
TCW Group's Genomic Health, Inc. position peaked at $768K in Q4 2018.
267 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2019.

Based on TCW Group's 13F filing for Q1 2019, filed 13 May 2019.